AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24691844 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 24691844 — intervention group
Group type: EXPERIMENTAL
Intervention: Almorexant 400 mg
Number of subjects: 44
Study 22878561 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamins (with or without minerals)
Number of subjects: 235
Study 22878561 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamins
Number of subjects: 235
Study 22878561 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil/omega-3 polyunsaturated fatty acids
Number of subjects: 235
Study 20394831 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 156
Study 20394831 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (AZA)
Number of subjects: 156
Study 18377400 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (10 mg increments, i.m. or i.v., at 10 min intervals, up to four doses)
Number of subjects: 62
Study 16544318 — intervention group
Group type: EXPERIMENTAL
Intervention: ASC-H with HPV testing
Number of subjects: 5060
Study 16544318 — intervention group
Group type: EXPERIMENTAL
Intervention: ASC-H
Number of subjects: 5060
Study 12719802 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid (0.5 mg/ml) perfusion before implantation
Number of subjects: 31
Study 12719802 — intervention group
Group type: COMPARATOR
Intervention: Control group (Euro-Collins solution without AA)
Number of subjects: 31
Study 10362452 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (Group CM, n = 9)
Number of subjects: 42
Study 10362452 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of calcium pyruvate (60%) and creatine (40%) (Group COM, n = 11)
Number of subjects: 42
Study 10362452 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium pyruvate (Group P, n = 11)
Number of subjects: 42
Study 10362452 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group PL)
Number of subjects: 42
Study 7574045 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 20
Study 7574045 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal Tube
Number of subjects: 20
Study 2126394 — intervention group
Group type: EXPERIMENTAL
Intervention: NORPLANT‐2 rod system
Number of subjects: 0
Study 2126394 — intervention group
Group type: COMPARATOR
Intervention: NORPLANT six capsule system
Number of subjects: 0
Study 527347 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 microgram clenbuterol
Number of subjects: 9
Study 527347 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 microgram salbutamol
Number of subjects: 9
Study 527347 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 31269409 — intervention group
Group type: EXPERIMENTAL
Intervention: Mymo Tracker
Number of subjects: 89
Study 31269409 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple Watch 2
Number of subjects: 89
Study 31269409 — intervention group
Group type: EXPERIMENTAL
Intervention: Misfit Shine 2 (right hip)
Number of subjects: 89
Study 31269409 — intervention group
Group type: COMPARATOR
Intervention: Samsung Gear Fit 2
Number of subjects: 89
Study 31269409 — intervention group
Group type: COMPARATOR
Intervention: Fitbit Charge 2
Number of subjects: 89
Study 31908438 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-trampoline training program
Number of subjects: 20
Study 29083221 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants told they carried elevated genetic susceptibility to depression
Number of subjects: 887
Study 29083221 — intervention group
Group type: COMPARATOR
Intervention: Participants told they did not carry genetic liability to depression or carried susceptibility to a different disorder
Number of subjects: 887
Study 25431052 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg and 8 mg
Number of subjects: 301
Study 25431052 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study 25431052 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 2 mg, 4 mg, or 8 mg
Number of subjects: 301
Study 25431052 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib
Number of subjects: 301
Study 23810265 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 147
Study 23810265 — intervention group
Group type: COMPARATOR
Intervention: Relaxation therapy (RT)
Number of subjects: 147
Study 21453381 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week muscle strength exercise intervention focused on lower limb strength exercises of light to moderate intensity (30-70% of one repetition maximum, 1RM)
Number of subjects: 40
Study 21453381 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week muscle strength exercise intervention focused on lower limb strength exercises of light to moderate intensity
Number of subjects: 40
Study 21453381 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 40
Study 18778905 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen-ozone combined with collagenase injection
Number of subjects: 108
Study 18778905 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 108
Study 16917950 — intervention group
Group type: EXPERIMENTAL
Intervention: methylphenidate (OROS and immediate release preparations)
Number of subjects: 106
Study 15310251 — intervention group
Group type: EXPERIMENTAL
Intervention: Health assessments (annual or 6-monthly) by health professionals with telephone follow-up and written report to a general practitioner
Number of subjects: 1569
Study 15310251 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1569
Study 11547717 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy (5 Gy on each of five days) followed by total mesorectal excision
Number of subjects: 1805
Study 11547717 — intervention group
Group type: COMPARATOR
Intervention: Total mesorectal excision alone
Number of subjects: 1805
Study 11547717 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy plus total mesorectal excision
Number of subjects: 1805
Study 9251545 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (25 mg)
Number of subjects: 868
Study 9251545 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (12.5 mg)
Number of subjects: 868
Study 9251545 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine (10 mg)
Number of subjects: 868
Study 9251545 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (5 mg)
Number of subjects: 868
Study 8347750 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaving messages on telephone answering machines
Number of subjects: 191
Study 8347750 — intervention group
Group type: COMPARATOR
Intervention: No message
Number of subjects: 191
Study 3327150 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 100 mg ofloxacin
Number of subjects: 137
Study 3327150 — intervention group
Group type: COMPARATOR
Intervention: Multiple dose of cotrimoxazole
Number of subjects: 137
Study 28836716 — intervention group
Group type: EXPERIMENTAL
Intervention: Real education (taste recognition test of supra‐ and sub‐threshold tastands)
Number of subjects: 28
Study 28836716 — intervention group
Group type: COMPARATOR
Intervention: Sham education
Number of subjects: 28
Study 26993252 — intervention group
Group type: EXPERIMENTAL
Intervention: Bionic Pancreas (BP)
Number of subjects: 19
Study 26993252 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 19
Study 22909265 — intervention group
Group type: COMPARATOR
Intervention: sham rTMS
Number of subjects: 192
Study 22909265 — intervention group
Group type: EXPERIMENTAL
Intervention: temporal rTMS (1 Hz over left auditory cortex)
Number of subjects: 192
Study 22909265 — intervention group
Group type: EXPERIMENTAL
Intervention: combined frontal and temporal rTMS (20 Hz over left frontal cortex followed by 1 Hz over left auditory cortex)
Number of subjects: 192
Study 23889039 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 149
Study 23889039 — intervention group
Group type: COMPARATOR
Intervention: Strength training
Number of subjects: 149
Study 20870179 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5 mm staple height
Number of subjects: 357
Study 20870179 — intervention group
Group type: COMPARATOR
Intervention: 4.8 mm staple height
Number of subjects: 357
Study 18390493 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo acupuncture alone (limited)
Number of subjects: 262
Study 18390493 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo acupuncture with augmented patient-practitioner relationship (augmented)
Number of subjects: 262
Study 18390493 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (observation)
Number of subjects: 262
Study 16751644 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist contraceptive advice and enhanced provision
Number of subjects: 613
Study 16751644 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 613
Study 12890370 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch (HES) solution, equal to estimated blood loss (EBL)
Number of subjects: 42
Study 12890370 — intervention group
Group type: COMPARATOR
Intervention: Lactated Ringer's solution (LRS), equal to three times the EBL
Number of subjects: 42
Study 10523748 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene arm (treatment)
Number of subjects: 0
Study 10523748 — intervention group
Group type: COMPARATOR
Intervention: No beta-carotene arm (control)
Number of subjects: 0
Study 8724088 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with spinal deformity due to tuberculosis
Number of subjects: 26
Study 8724088 — intervention group
Group type: COMPARATOR
Intervention: Normal adult volunteers
Number of subjects: 26
Study 1764952 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin tablet (200 mg)
Number of subjects: 32
Study 1764952 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin tablet (300 mg)
Number of subjects: 32
Study 1764952 — intervention group
Group type: COMPARATOR
Intervention: Ofloxacin solution (200 mg)
Number of subjects: 32
Study 1764952 — intervention group
Group type: COMPARATOR
Intervention: Ofloxacin solution (300 mg)
Number of subjects: 32
Study 7121050 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative iron therapy
Number of subjects: 37
Study 7121050 — intervention group
Group type: COMPARATOR
Intervention: No iron therapy
Number of subjects: 37
Study 31721173 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 626
Study 31721173 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 626
Study 30924071 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral medication
Number of subjects: 400
Study 30924071 — intervention group
Group type: EXPERIMENTAL
Intervention: One injection per month
Number of subjects: 400
Study 30924071 — intervention group
Group type: EXPERIMENTAL
Intervention: 31-39 injections once every 3 months
Number of subjects: 400
Study 30924071 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral medications (adverse events)
Number of subjects: 400
Study 30063901 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate injection
Number of subjects: 76
Study 30063901 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection (0.9% saline)
Number of subjects: 76
Study 27555198 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 μg morphine
Number of subjects: 195
Study 27555198 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 μg morphine
Number of subjects: 195
Study 27555198 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 μg morphine + 75 μg clonidine
Number of subjects: 195
Study 25467394 — intervention group
Group type: EXPERIMENTAL
Intervention: Body weight-supported treadmill training (BWSTT)
Number of subjects: 43
Study 25467394 — intervention group
Group type: COMPARATOR
Intervention: Overground gait training
Number of subjects: 43
Study 25467394 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups (BWSTT and overground gait training)
Number of subjects: 43
Study 23046005 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 ml mouthwash
Number of subjects: 62
Study 23046005 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 ml mouthwash
Number of subjects: 62
Study 23046005 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 ml mouthwash
Number of subjects: 62
Study 23046005 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ml mouthwash
Number of subjects: 62
Study 23046005 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 ml mouthwash
Number of subjects: 62
Study 19933538 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 0.5 mg/kg
Number of subjects: 102
Study 19933538 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 4.0 mg/kg
Number of subjects: 102
Study 19933538 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex 8.0 mg/kg
Number of subjects: 102
Study 19933538 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugammadex (various doses)
Number of subjects: 102
Study 17881290 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term androgen deprivation (STAD) plus radiotherapy
Number of subjects: 586
Study 17881290 — intervention group
Group type: COMPARATOR
Intervention: Long-term androgen deprivation (LTAD) plus radiotherapy
Number of subjects: 586
Study 17881290 — intervention group
Group type: EXPERIMENTAL
Intervention: COX‐2 expression (as a continuous covariate)
Number of subjects: 586
Study 15982134 — intervention group
Group type: EXPERIMENTAL
Intervention: Probabilistic category feedback
Number of subjects: 0
Study 15982134 — intervention group
Group type: COMPARATOR
Intervention: Deterministic category feedback
Number of subjects: 0
Study 11823753 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (normal strength)
Number of subjects: 10
Study 11823753 — intervention group
Group type: EXPERIMENTAL
Intervention: Orange juice (normal strength)
Number of subjects: 10
Study 11823753 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple juice (normal strength)
Number of subjects: 10
Study 11823753 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (25% strength)
Number of subjects: 10
Study 11823753 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 10
Study 9737819 — intervention group
Group type: EXPERIMENTAL
Intervention: Avitriptan 50 mg capsule administered under fasted condition and at various intervals (30 min, 1, 2, and 4 h) after a standard high fat meal
Number of subjects: 0
Study 9737819 — intervention group
Group type: EXPERIMENTAL
Intervention: Avitriptan 50 mg capsule administered after a high protein and a high carbohydrate meal
Number of subjects: 0
Study 9737819 — intervention group
Group type: EXPERIMENTAL
Intervention: Avitriptan 50 mg 14C-labeled solution administered after a standard high fat meal
Number of subjects: 0
Study 9737819 — intervention group
Group type: EXPERIMENTAL
Intervention: Avitriptan 150 mg capsule administered after a standard high fat meal
Number of subjects: 0
Study 9737819 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine pretreatment before avitriptan administration
Number of subjects: 0
Study 8032702 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron plus dexamethasone
Number of subjects: 63
Study 8032702 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide plus dexamethasone plus diphenhydramine
Number of subjects: 63
Study 2920503 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 31
Study 2920503 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 31
Study 2920503 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 31
Study 31537118 — intervention group
Group type: EXPERIMENTAL
Intervention: Low neuroticism
Number of subjects: 200
Study 31537118 — intervention group
Group type: EXPERIMENTAL
Intervention: High extraversion
Number of subjects: 200
Study 31537118 — intervention group
Group type: EXPERIMENTAL
Intervention: High conscientiousness
Number of subjects: 200
Study 31537118 — intervention group
Group type: EXPERIMENTAL
Intervention: Personality traits
Number of subjects: 200
Study 29687674 — intervention group
Group type: EXPERIMENTAL
Intervention: Intubating laryngeal tube (iLTS‐D)
Number of subjects: 30
Study 29687674 — intervention group
Group type: COMPARATOR
Intervention: Intubating laryngeal mask (iLMA)
Number of subjects: 30
Study 27756322 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative oral elemental diet (Elental®, 300 kcal/day)
Number of subjects: 43
Study 24732649 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Figueroa technique
Number of subjects: 30
Study 24732649 — intervention group
Group type: COMPARATOR
Intervention: Modified Grayson technique
Number of subjects: 30
Study 24732649 — intervention group
Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 30
Study 22556178 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol and 1 mg citric acid
Number of subjects: 5
Study 22556178 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol alone
Number of subjects: 5
Study 22556178 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 20119583 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurocognitive tests administered to schizophrenia patients
Number of subjects: 114
Study 20119583 — intervention group
Group type: COMPARATOR
Intervention: Neurocognitive tests administered to healthy controls
Number of subjects: 114
Study 18086727 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 539
Study 18086727 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 539
Study 16152823 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuzheng Jiangnian Capsule (FZJN)
Number of subjects: 90
Study 16152823 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound Salviae droplet pill (CSDP)
Number of subjects: 90
Study 16152823 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (ASP)
Number of subjects: 90
Study 16152823 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 90
Study 13678873 — intervention group
Group type: EXPERIMENTAL
Intervention: Ximelagatran (combined groups)
Number of subjects: 1883
Study 13678873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1883
Study 11770234 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC) for at least 4 hours per day in not more than 3 sittings
Number of subjects: 28
Study 11770234 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care: incubator or open care system)
Number of subjects: 28
Study 11770234 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care (KMC)
Number of subjects: 28
Study 11770234 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 28
Study 8993243 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aprotinin (2 x 10(6) KIU or 280 mg in the pump)
Number of subjects: 36
Study 8993243 — intervention group
Group type: COMPARATOR
Intervention: Control group (no aprotinin)
Number of subjects: 36
Study 7952372 — intervention group
Group type: EXPERIMENTAL
Intervention: Piroxicam
Number of subjects: 50
Study 7952372 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 50
Study 2962617 — intervention group
Group type: EXPERIMENTAL
Intervention: Ioxaglate (Hexabrix)
Number of subjects: 107
Study 2962617 — intervention group
Group type: COMPARATOR
Intervention: Iohexol (Omnipaque)
Number of subjects: 107
Study 2199732 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucagon (2 micrograms kg‐1 hr‐1)
Number of subjects: 5
Study 2199732 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin (0.125 U kg‐1 hr‐1)
Number of subjects: 5
Study 2199732 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 5
Study 5090825 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive exercise of the lower limb during surgery (using a motorized foot mover, pedalling one leg)
Number of subjects: 47
Study 5090825 — intervention group
Group type: COMPARATOR
Intervention: Control (unpedalled leg)
Number of subjects: 47
Study 5090825 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive exercise of the lower limb during surgery
Number of subjects: 47
Study 31142943 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% Vitamin K cream
Number of subjects: 63
Study 31142943 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% phenytoin cream
Number of subjects: 63
Study 31142943 — intervention group
Group type: COMPARATOR
Intervention: Eucerin
Number of subjects: 63
Study 28427763 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation program delivered via online video-conferencing for 12 weeks
Number of subjects: 17
Study 25836986 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT) from healthy donors
Number of subjects: 50
Study 25836986 — intervention group
Group type: COMPARATOR
Intervention: Autologous fecal microbiota (control)
Number of subjects: 50
Study 25836986 — intervention group
Group type: EXPERIMENTAL
Intervention: FMT group
Number of subjects: 50
Study 25836986 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 23725684 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (group P, n = 23)
Number of subjects: 44
Study 23725684 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane (group S, n = 21)
Number of subjects: 44
Study 23725684 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (group P)
Number of subjects: 44
Study 22776976 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric LDH group
Number of subjects: 32
Study 22776976 — intervention group
Group type: COMPARATOR
Intervention: Adult LDH group
Number of subjects: 32
Study 19182362 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate
Number of subjects: 0
Study 19182362 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17192957 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 102
Study 17192957 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 102
Study 15765858 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided puncture of the femoral artery
Number of subjects: 112
Study 15765858 — intervention group
Group type: COMPARATOR
Intervention: Traditional palpation-guided vessel cannulation
Number of subjects: 112